Why do major pharmaceutical companies love BTK? This is closely related to its immense market potential, wide range of indications, clinically prominent efficacy, and safety.
Benegrastim is a fusion protein targeting CSF-3R (GCSFR). It is used for the treatment of neutropenia, fever, breast cancer, Parkinson's disease, and other conditions.
mRNA vaccines involve delivering mRNA encoding antigen proteins into the human body, which is then translated directly into antigens, inducing an immune response.
Over the past 170 years, what transformations and breakthroughs has Pfizer experienced? What insights does its development journey offer to pharmaceutical companies?